Author
|
Year
|
Design
|
Country
|
Case/Exposure
|
Control/Comparator
|
Total N
|
Age cases (Yr)
|
Age control (Yr)
|
Male cases (%)
|
Male control (%)
|
---|
D’Agata (a) [17]
|
2006
|
CC, matched
|
USA, Italy
|
CRPA
|
Non-P. aeruginosa
|
82
|
61
|
60
|
73
|
44
|
DalBen [42]
|
2013
|
P, cohort
|
Brazil
|
MRAC and CRPA
|
Non-MRAC and non-CRPA
|
325
|
44
|
41
|
59
|
41
|
Djordjevic [43]
|
2013
|
P, cohort
|
Serbia
|
CRPA
|
CSPA
|
261
|
59.2
|
61.4
|
80.8
|
64.9
|
Eagye (a) [44]
|
2009
|
CC, control
|
USA
|
MRPA
|
MSPA
|
183
|
66.4
|
66.1
|
58.6
|
59.2
|
Eagye (b) [44]
|
2009
|
CC, control
|
USA
|
MRPA
|
Non-P. aeruginosa
|
182
|
66.4
|
57.4
|
58.6
|
50.9
|
Fortaleza (a) [45]
|
2006
|
CC, matched
|
Brazil
|
IRPA
|
Control (NR)
|
324
|
median 45
|
median 44
|
68.5
|
60.2
|
Furtado [46]
|
2009
|
CC, matched
|
Brazil
|
IRPA
|
Without IRPA
|
245
|
50
|
54
|
68.3
|
59.3
|
Furtado [47]
|
2010
|
CC, matched
|
Brazil
|
IRPA
|
Non-IRPA
|
295
|
54
|
54
|
70.7
|
56.5
|
Harris [50]
|
2002
|
CC, matched
|
USA
|
IRPA
|
Without IRPA
|
866
|
55.7
|
49.4
|
39.1
|
39.1
|
Harris [51]
|
2011
|
P, cohort
|
USA
|
IRPA
|
Non-IRPA
|
3146
|
56.7
|
55.7
|
61.9
|
56.7
|
Kohlenberg [54]
|
2010
|
CC, unmatched
|
Germany
|
CRPA
|
CSPA
|
33
|
median 60
|
median 44.4
|
53.3
|
72.2
|
Lautenbach [55]
|
2010
|
CC, unmatched
|
USA
|
IRPA
|
ISPA
|
2542
|
61 (total)
|
61 (total)
|
63.3
|
56.1
|
Lee [56]
|
2015
|
CC, matched
|
Taiwan
|
CRPA
|
All susceptible P. aeruginosa
|
75
|
61.6
|
62
|
48
|
48
|
Lin [57]
|
2016
|
CC, unmatched
|
Taiwan
|
CRPA
|
CSPA
|
164
|
66.6
|
63.5
|
72
|
67.1
|
Luyt [58]
|
2014
|
P, cohort
|
France
|
CRPA
|
CSPA
|
169
|
57.6
|
57.9
|
65
|
66
|
Onguru [59]
|
2008
|
P, cohort
|
Turkey
|
IRPA
|
ISPA
|
170
|
45.9
|
49.7
|
72
|
66.3
|
Pena [60]
|
2007
|
P, cohort
|
Spain
|
CRPA
|
CSPA
|
254
|
59.8
|
57.1
|
60
|
65
|
Pereira [61]
|
2008
|
CC, unmatched
|
Brazil
|
IRPA
|
ISPA
|
59
|
51.8
|
50.7
|
70
|
55
|
Tam [62]
|
2007
|
CC, unmatched
|
USA
|
CRPA
|
Pan-susceptible P. aeruginosa
|
51
|
50
|
64
|
33
|
73
|
Tuon [40]
|
2012
|
CC, unmatched
|
Brazil
|
CRPA
|
CSPA
|
77
|
46.4
|
49
|
75.9
|
70.8
|
Zavascki (a) [64]
|
2005
|
CC, unmatched
|
Brazil
|
IRPA
|
Non P. aeruginosa
|
186
|
58
|
51
|
60
|
53
|
Zavascki (b) [64]
|
2005
|
CC, unmatched
|
Brazil
|
IRPA
|
ISPA
|
158
|
58
|
51
|
60
|
66
|
Zhang [65]
|
2009
|
CC, unmatched
|
China
|
CRPA
|
CSPA
|
34
|
61
|
50
|
NR
|
NR
|
- CC case-control, CRPA carbapenem-resistantP. aeruginosa, CSPA carbapenem-susceptible P.aeruginosa, ICU Intensive Care Unit, IRPA imipenem-resistant P. aeruginosa, ISPA imipenem-susceptible P.aeruginosa, MRAC meropenem-resistant Acinetobacter baumannii, MRPA meropenem-resistant P. aeruginosa, MSPA meropenem-susceptible P. aeruginosa, NR not reported,k P parallel, SICU Surgical Intensive Care Unit, YR year